CD274 and neoplasm: Similarly, 100% of the MC38-PD-L1 KO tumor-bearing mice that received docetaxel + NHS-IL-12 were alive at the end of the study resulting in a significantly increased survival benefit when compared to the untreated cohort (29 days) (purple line; p = 0.0001; Fig. 5D).